Chen Y-W, Wang L, Panian J, et al. Treatment Landscape of Renal Cell Carcinoma. Curr Treat Options Oncol. 2023;24(12):1889–916.

Article  PubMed  PubMed Central  Google Scholar 

Perazella MA, Dreicer R, Rosner MH. Renal cell carcinoma for the nephrologist. Kidney Int. 2018;94(3):471–83.

Article  PubMed  Google Scholar 

Rizzo M, Caliò A, Brunelli M, et al. Clinico-pathological implications of the 2022 WHO renal cell carcinoma classification. Cancer Treat Rev. 2023;116:102558.

Article  PubMed  Google Scholar 

Li Y, Lih T-SM, Dhanasekaran SM et al. Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness. Cancer Cell 2023, 41(1).

Leibovich BC, Lohse CM, Cheville JC, et al. Predicting Oncologic outcomes in Renal Cell Carcinoma after surgery. Eur Urol. 2018;73(5):772–80.

Article  PubMed  Google Scholar 

Chen S, Jiang L, Gao F, et al. Machine learning-based pathomics signature could act as a novel prognostic marker for patients with clear cell renal cell carcinoma. Br J Cancer. 2022;126(5):771–7.

Article  PubMed  CAS  Google Scholar 

Chen L-X, Zeng S-J, Liu X-D, et al. Cell-cell communications shape tumor microenvironment and predict clinical outcomes in clear cell renal carcinoma. J Translational Med. 2023;21(1):113.

Article  CAS  Google Scholar 

Parker WP, Cheville JC, Frank I, et al. Application of the stage, size, Grade, and necrosis (SSIGN) score for Clear Cell Renal Cell Carcinoma in Contemporary patients. Eur Urol. 2017;71(4):665–73.

Article  PubMed  Google Scholar 

Yang G, Nie P, Yan L, et al. The radiomics-based tumor heterogeneity adds incremental value to the existing prognostic models for predicting outcome in localized clear cell renal cell carcinoma: a multicenter study. Eur J Nucl Med Mol Imaging. 2022;49(8):2949–59.

Article  PubMed  Google Scholar 

Zheng Z, Chen Z, Xie Y, et al. Development and validation of a CT-based nomogram for preoperative prediction of clear cell renal cell carcinoma grades. Eur Radiol. 2021;31(8):6078–86.

Article  PubMed  Google Scholar 

Lin F, Ma C, Xu J, et al. A CT-based deep learning model for predicting the nuclear grade of clear cell renal cell carcinoma. Eur J Radiol. 2020;129:109079.

Article  PubMed  Google Scholar 

Wang R, Dai W, Gong J, et al. Development of a novel combined nomogram model integrating deep learning-pathomics, radiomics and immunoscore to predict postoperative outcome of colorectal cancer lung metastasis patients. J Hematol Oncol. 2022;15(1):11.

Article  PubMed  PubMed Central  Google Scholar 

Fu N, Fu W, Chen H, et al. A deep-learning radiomics-based lymph node metastasis predictive model for pancreatic cancer: a diagnostic study. Int J Surg (London England). 2023;109(8):2196–203.

Article  Google Scholar 

Huang W, Wang C, Wang Y, et al. Predicting malnutrition in gastric cancer patients using computed tomography(CT) deep learning features and clinical data. Clin Nutr. 2024;43(3):881–91.

Article  PubMed  Google Scholar 

Wang X, Xie T, Luo J, et al. Radiomics predicts the prognosis of patients with locally advanced breast cancer by reflecting the heterogeneity of tumor cells and the tumor microenvironment. Breast cancer Research: BCR. 2022;24(1):20.

Article  PubMed  PubMed Central  CAS  Google Scholar 

He H, Jin Z, Dai J, et al. Computed tomography-based radiomics prediction of CTLA4 expression and prognosis in clear cell renal cell carcinoma. Cancer Med. 2023;12(6):7627–38.

Article  PubMed  CAS  Google Scholar 

Mathew G, Agha R, Albrecht J, et al. STROCSS 2021: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery. Int J Surg (London England). 2021;96:106165.

Article  Google Scholar 

Neeman E, Gresham G, Ovasapians N, et al. Comparing physician and Nurse Eastern Cooperative Oncology Group Performance Status (ECOG-PS) ratings as predictors of clinical outcomes in patients with Cancer. Oncologist. 2019;24(12):e1460–6.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Asai N, Ohashi W, Sakanashi D, et al. Combination of sequential organ failure Assessment (SOFA) score and Charlson Comorbidity Index (CCI) could predict the severity and prognosis of candidemia more accurately than the Acute Physiology, Age, Chronic Health evaluation II (APACHE II) score. BMC Infect Dis. 2021;21(1):77.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kroeger N, Rampersaud EN, Patard JJ, et al. Prognostic value of microvascular invasion in predicting the cancer specific survival and risk of metastatic disease in renal cell carcinoma: a multicenter investigation. J Urol. 2012;187(2):418–23.

Article  PubMed  Google Scholar 

Bedke J, Heide J, Ribback S, et al. Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice. BJU Int. 2018;121(1):84–92.

Article  PubMed  CAS  Google Scholar 

Warren AY, Harrison D. WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversies. World J Urol. 2018;36(12):1913–26.

Article  PubMed  PubMed Central  Google Scholar 

Zanfardino M, Pane K, Mirabelli P et al. TCGA-TCIA impact on Radiogenomics Cancer Research: a systematic review. Int J Mol Sci 2019, 20(23).

Nazari M, Shiri I, Zaidi H. Radiomics-based machine learning model to predict risk of death within 5-years in clear cell renal cell carcinoma patients. Comput Biol Med. 2021;129:104135.

Article  PubMed  Google Scholar 

Nie P, Yang G, Wang Y, et al. A CT-based deep learning radiomics nomogram outperforms the existing prognostic models for outcome prediction in clear cell renal cell carcinoma: a multicenter study. Eur Radiol. 2023;33(12):8858–68.

Article  PubMed  Google Scholar 

Liu T-T, Li R, Huo C, et al. Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-cancer Analysis. Front cell Dev Biology. 2021;9:682002.

Article  Google Scholar 

Gene Ontology Consortium. Going forward. Nucleic Acids Res. 2015;43(Database issue):D1049–56.

Article  Google Scholar 

Kanehisa M, Furumichi M, Tanabe M, et al. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45(D1):D353–61.

Article  PubMed  CAS  Google Scholar 

Doncheva NT, Morris JH, Gorodkin J, et al. Cytoscape StringApp: Network Analysis and Visualization of Proteomics Data. J Proteome Res. 2019;18(2):623–32.

Article  PubMed  CAS  Google Scholar 

Jardim DL, Goodman A, de Melo Gagliato D, et al. The challenges of Tumor Mutational Burden as an Immunotherapy Biomarker. Cancer Cell. 2021;39(2):154–73.

Article  PubMed  CAS  Google Scholar 

Yoshihara K, Shahmoradgoli M, Martínez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.

Article  PubMed  Google Scholar 

Su Q, Zhu Y, He B, et al. A novel tumor purity and immune infiltration-related model for predicting distant metastasis-free survival in prostate cancer. Eur J Med Res. 2023;28(1):545.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yao W, Liu X, He Y, et al. ScRNA-seq and bulk RNA-seq reveal the characteristics of ferroptosis and establish a risk signature in cholangiocarcinoma. Mol Ther Oncolytics. 2022;27:48–60.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Fang H, Sheng S, Chen B, et al. A Pan-cancer analysis of the oncogenic role of Cell Division Cycle-Associated protein 4 (CDCA4) in human tumors. Front Immunol. 2022;13:826337.

Article  PubMed  PubMed Central  CAS